{"id":17261,"date":"2022-04-18T09:30:37","date_gmt":"2022-04-18T08:30:37","guid":{"rendered":"https:\/\/psychedelichealth.co.uk\/?p=17261"},"modified":"2022-04-14T16:30:33","modified_gmt":"2022-04-14T15:30:33","slug":"expanding-research-into-psychedelic-therapies","status":"publish","type":"post","link":"https:\/\/psychedelichealth.co.uk\/2022\/04\/18\/expanding-research-into-psychedelic-therapies\/","title":{"rendered":"Expanding research into psychedelic therapies"},"content":{"rendered":"<h3 class=\"p1\"><b>SABI Mind and Reverie Psychedelics have partnered to expand research into psychedelic-assisted therapies.<\/b><\/h3>\n<p class=\"p1\"><a href=\"https:\/\/www.sabimind.com\/\" target=\"_blank\" rel=\"noopener\">SABI Mind<\/a> (SABI) has announced Canada&#8217;s first research partnership with US-based <a href=\"https:\/\/www.reveriepsychedelics.com\/\" target=\"_blank\" rel=\"noopener\">Reverie Psychedelics<\/a>.<span class=\"Apple-converted-space\">\u00a0<\/span><\/p>\n<p class=\"p1\">The collaboration will provide academics and psychedelic companies researching psychedelic therapies access to SABI clinics, qualified clinical staff, and Reverie&#8217;s expanding suite of clinical trial support services as these novel treatments work their way through the rigorous drug development process.<\/p>\n<div style=\"clear:both; margin-top:0em; margin-bottom:1em;\"><a href=\"https:\/\/psychedelichealth.co.uk\/2021\/09\/30\/data-shows-combination-psilocybin-therapy-effective-for-tbi-and-ptsd\/\" target=\"_blank\" rel=\"dofollow\" class=\"uf9b32668b604244329956c08a03f0e48\"><style> .uf9b32668b604244329956c08a03f0e48 { padding:0px; margin: 0; padding-top:1em!important; padding-bottom:1em!important; width:100%; display: block; font-weight:bold; background-color:#eaeaea; border:0!important; border-left:4px solid #34495E!important; text-decoration:none; } .uf9b32668b604244329956c08a03f0e48:active, .uf9b32668b604244329956c08a03f0e48:hover { opacity: 1; transition: opacity 250ms; webkit-transition: opacity 250ms; text-decoration:none; } .uf9b32668b604244329956c08a03f0e48 { transition: background-color 250ms; webkit-transition: background-color 250ms; opacity: 1; transition: opacity 250ms; webkit-transition: opacity 250ms; } .uf9b32668b604244329956c08a03f0e48 .ctaText { font-weight:bold; color:inherit; text-decoration:none; font-size: 16px; } .uf9b32668b604244329956c08a03f0e48 .postTitle { color:#000000; text-decoration: underline!important; font-size: 16px; } .uf9b32668b604244329956c08a03f0e48:hover .postTitle { text-decoration: underline!important; } <\/style><div style=\"padding-left:1em; padding-right:1em;\"><span class=\"ctaText\">See also<\/span>&nbsp; <span class=\"postTitle\">Data shows combination psilocybin therapy effective for TBI and PTSD<\/span><\/div><\/a><\/div>\n<p class=\"p1\">Robert Wallace, Founder and CEO of Reverie, commented: \u201dI am elated to have the opportunity to work alongside the outstanding team and research-experienced physicians and staff at SABI.<\/p>\n<p class=\"p1\">\u201dThis is our first Canadian clinical research partnership and will provide researchers from\u00a0Canada, the US and around the globe with qualified clinical trial sites and SABI patients with access to emerging psychedelic treatment options.&#8221;<\/p>\n<p class=\"p1\">Having developed and co-ordinated the Canadian Psychedelic Survey (CPS), SABI has already established itself as an academic leader in the psychedelic treatment space. This\u00a0collaboration with Reverie will support and expand SABI&#8217;s clinical trial goals and capabilities.<\/p>\n<p class=\"p1\">&#8220;While there is a growing amount of evidence regarding the safety and efficacy of psychedelic-assisted therapies, this is the dawn of the Renaissance in psychedelic drug research and development,&#8221; says Philippe Lucas Ph.D., President of SABI Mind.<span class=\"Apple-converted-space\">\u00a0<\/span><\/p>\n<p class=\"p1\">&#8220;Dozens of companies and academic institutions are currently developing psychedelic medicines, and SABI is pleased to partner with the skilled and experienced team at Reverie to support research into novel psychedelic-based treatments and expand our understanding of how they might improve the health and quality of life of chronically ill patients around the world.\u201d<\/p>\n","protected":false},"excerpt":{"rendered":"<p>A new partnership is aiming to provide researchers from\u00a0Canada, the US and around the globe with qualified clinical trial sites.<\/p>\n","protected":false},"author":20,"featured_media":17262,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_cbd_carousel_blocks":"[]","content-type":"","_monsterinsights_skip_tracking":false,"_monsterinsights_sitenote_active":false,"_monsterinsights_sitenote_note":"","_monsterinsights_sitenote_category":0,"footnotes":""},"categories":[215],"tags":[48,221,225],"yoast_head":"<!-- This site is optimized with the Yoast SEO Premium plugin v18.1 (Yoast SEO v22.4) - https:\/\/yoast.com\/wordpress\/plugins\/seo\/ -->\n<title>Expanding research into psychedelic therapies<\/title>\n<meta name=\"description\" content=\"SABI Mind and Reverie Psychedelics have partnered to expand research into psychedelic-assisted therapies.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/34.142.66.208\/2022\/04\/18\/expanding-research-into-psychedelic-therapies\/\" \/>\n<meta property=\"og:locale\" content=\"en_GB\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Expanding research into psychedelic therapies\" \/>\n<meta property=\"og:description\" content=\"SABI Mind and Reverie Psychedelics have partnered to expand research into psychedelic-assisted therapies.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/34.142.66.208\/2022\/04\/18\/expanding-research-into-psychedelic-therapies\/\" \/>\n<meta property=\"og:site_name\" content=\"Psychedelic Health\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/Cannabis-Health-Magazine-1047415772315886\/?ref=bookmarks\" \/>\n<meta property=\"article:published_time\" content=\"2022-04-18T08:30:37+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2022-04-14T15:30:33+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/34.142.66.208\/wp-content\/uploads\/2022\/04\/AdobeStock_288862744.jpeg\" \/>\n\t<meta property=\"og:image:width\" content=\"1200\" \/>\n\t<meta property=\"og:image:height\" content=\"585\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"Stephanie Price\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:creator\" content=\"@https:\/\/twitter.com\/steph_jprice\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Stephanie Price\" \/>\n\t<meta name=\"twitter:label2\" content=\"Estimated reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\/\/34.142.66.208\/2022\/04\/18\/expanding-research-into-psychedelic-therapies\/\",\"url\":\"https:\/\/34.142.66.208\/2022\/04\/18\/expanding-research-into-psychedelic-therapies\/\",\"name\":\"Expanding research into psychedelic therapies\",\"isPartOf\":{\"@id\":\"https:\/\/34.142.66.208\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/34.142.66.208\/2022\/04\/18\/expanding-research-into-psychedelic-therapies\/#primaryimage\"},\"image\":{\"@id\":\"https:\/\/34.142.66.208\/2022\/04\/18\/expanding-research-into-psychedelic-therapies\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/psychedelichealth.co.uk\/wp-content\/uploads\/2022\/04\/AdobeStock_288862744.jpeg\",\"datePublished\":\"2022-04-18T08:30:37+00:00\",\"dateModified\":\"2022-04-14T15:30:33+00:00\",\"author\":{\"@id\":\"https:\/\/34.142.66.208\/#\/schema\/person\/188c12739a5906cf0b69fbf53f517f12\"},\"description\":\"SABI Mind and Reverie Psychedelics have partnered to expand research into psychedelic-assisted therapies.\",\"breadcrumb\":{\"@id\":\"https:\/\/34.142.66.208\/2022\/04\/18\/expanding-research-into-psychedelic-therapies\/#breadcrumb\"},\"inLanguage\":\"en-GB\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/34.142.66.208\/2022\/04\/18\/expanding-research-into-psychedelic-therapies\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-GB\",\"@id\":\"https:\/\/34.142.66.208\/2022\/04\/18\/expanding-research-into-psychedelic-therapies\/#primaryimage\",\"url\":\"https:\/\/psychedelichealth.co.uk\/wp-content\/uploads\/2022\/04\/AdobeStock_288862744.jpeg\",\"contentUrl\":\"https:\/\/psychedelichealth.co.uk\/wp-content\/uploads\/2022\/04\/AdobeStock_288862744.jpeg\",\"width\":1200,\"height\":585,\"caption\":\"Expanding research into psychedelic therapies\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/34.142.66.208\/2022\/04\/18\/expanding-research-into-psychedelic-therapies\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/34.142.66.208\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Expanding research into psychedelic therapies\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/34.142.66.208\/#website\",\"url\":\"https:\/\/34.142.66.208\/\",\"name\":\"Psychedelic Health\",\"description\":\"News\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/34.142.66.208\/?s={search_term_string}\"},\"query-input\":\"required name=search_term_string\"}],\"inLanguage\":\"en-GB\"},{\"@type\":\"Person\",\"@id\":\"https:\/\/34.142.66.208\/#\/schema\/person\/188c12739a5906cf0b69fbf53f517f12\",\"name\":\"Stephanie Price\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-GB\",\"@id\":\"https:\/\/34.142.66.208\/#\/schema\/person\/image\/\",\"url\":\"https:\/\/psychedelichealth.co.uk\/wp-content\/uploads\/2023\/05\/avatar_user_20_1684313043-96x96.jpg\",\"contentUrl\":\"https:\/\/psychedelichealth.co.uk\/wp-content\/uploads\/2023\/05\/avatar_user_20_1684313043-96x96.jpg\",\"caption\":\"Stephanie Price\"},\"description\":\"Stephanie is the editor of Psychedelic Health. Contact: stephanie@psych.global. Stephanie is a journalist writing about science, research, policy and industry developments in cannabis, CBD and psychedelics. In 2013 Stephanie gained her BA in English and Media, focusing on journalism and propaganda, and in 2015, received her National Council for the Training of Journalists (NCTJ) diploma whilst working as a reporter in North Wales. Stephanie has a specialism in Medical Cannabis: The Health Effects of THC and CBD through the University of Colorado, Boulder, and a certificate from the Medical Cannabis Clinicians Society on \\\"Medical Cannabis Explained\\\".\",\"sameAs\":[\"https:\/\/psychedelichealth.co.uk\",\"https:\/\/twitter.com\/https:\/\/twitter.com\/steph_jprice\"],\"url\":\"https:\/\/psychedelichealth.co.uk\/author\/stephanieprice\/\"}]}<\/script>\n<!-- \/ Yoast SEO Premium plugin. -->","yoast_head_json":{"title":"Expanding research into psychedelic therapies","description":"SABI Mind and Reverie Psychedelics have partnered to expand research into psychedelic-assisted therapies.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/34.142.66.208\/2022\/04\/18\/expanding-research-into-psychedelic-therapies\/","og_locale":"en_GB","og_type":"article","og_title":"Expanding research into psychedelic therapies","og_description":"SABI Mind and Reverie Psychedelics have partnered to expand research into psychedelic-assisted therapies.","og_url":"https:\/\/34.142.66.208\/2022\/04\/18\/expanding-research-into-psychedelic-therapies\/","og_site_name":"Psychedelic Health","article_publisher":"https:\/\/www.facebook.com\/Cannabis-Health-Magazine-1047415772315886\/?ref=bookmarks","article_published_time":"2022-04-18T08:30:37+00:00","article_modified_time":"2022-04-14T15:30:33+00:00","og_image":[{"width":1200,"height":585,"url":"https:\/\/34.142.66.208\/wp-content\/uploads\/2022\/04\/AdobeStock_288862744.jpeg","type":"image\/jpeg"}],"author":"Stephanie Price","twitter_card":"summary_large_image","twitter_creator":"@https:\/\/twitter.com\/steph_jprice","twitter_misc":{"Written by":"Stephanie Price","Estimated reading time":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/34.142.66.208\/2022\/04\/18\/expanding-research-into-psychedelic-therapies\/","url":"https:\/\/34.142.66.208\/2022\/04\/18\/expanding-research-into-psychedelic-therapies\/","name":"Expanding research into psychedelic therapies","isPartOf":{"@id":"https:\/\/34.142.66.208\/#website"},"primaryImageOfPage":{"@id":"https:\/\/34.142.66.208\/2022\/04\/18\/expanding-research-into-psychedelic-therapies\/#primaryimage"},"image":{"@id":"https:\/\/34.142.66.208\/2022\/04\/18\/expanding-research-into-psychedelic-therapies\/#primaryimage"},"thumbnailUrl":"https:\/\/psychedelichealth.co.uk\/wp-content\/uploads\/2022\/04\/AdobeStock_288862744.jpeg","datePublished":"2022-04-18T08:30:37+00:00","dateModified":"2022-04-14T15:30:33+00:00","author":{"@id":"https:\/\/34.142.66.208\/#\/schema\/person\/188c12739a5906cf0b69fbf53f517f12"},"description":"SABI Mind and Reverie Psychedelics have partnered to expand research into psychedelic-assisted therapies.","breadcrumb":{"@id":"https:\/\/34.142.66.208\/2022\/04\/18\/expanding-research-into-psychedelic-therapies\/#breadcrumb"},"inLanguage":"en-GB","potentialAction":[{"@type":"ReadAction","target":["https:\/\/34.142.66.208\/2022\/04\/18\/expanding-research-into-psychedelic-therapies\/"]}]},{"@type":"ImageObject","inLanguage":"en-GB","@id":"https:\/\/34.142.66.208\/2022\/04\/18\/expanding-research-into-psychedelic-therapies\/#primaryimage","url":"https:\/\/psychedelichealth.co.uk\/wp-content\/uploads\/2022\/04\/AdobeStock_288862744.jpeg","contentUrl":"https:\/\/psychedelichealth.co.uk\/wp-content\/uploads\/2022\/04\/AdobeStock_288862744.jpeg","width":1200,"height":585,"caption":"Expanding research into psychedelic therapies"},{"@type":"BreadcrumbList","@id":"https:\/\/34.142.66.208\/2022\/04\/18\/expanding-research-into-psychedelic-therapies\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/34.142.66.208\/"},{"@type":"ListItem","position":2,"name":"Expanding research into psychedelic therapies"}]},{"@type":"WebSite","@id":"https:\/\/34.142.66.208\/#website","url":"https:\/\/34.142.66.208\/","name":"Psychedelic Health","description":"News","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/34.142.66.208\/?s={search_term_string}"},"query-input":"required name=search_term_string"}],"inLanguage":"en-GB"},{"@type":"Person","@id":"https:\/\/34.142.66.208\/#\/schema\/person\/188c12739a5906cf0b69fbf53f517f12","name":"Stephanie Price","image":{"@type":"ImageObject","inLanguage":"en-GB","@id":"https:\/\/34.142.66.208\/#\/schema\/person\/image\/","url":"https:\/\/psychedelichealth.co.uk\/wp-content\/uploads\/2023\/05\/avatar_user_20_1684313043-96x96.jpg","contentUrl":"https:\/\/psychedelichealth.co.uk\/wp-content\/uploads\/2023\/05\/avatar_user_20_1684313043-96x96.jpg","caption":"Stephanie Price"},"description":"Stephanie is the editor of Psychedelic Health. Contact: stephanie@psych.global. Stephanie is a journalist writing about science, research, policy and industry developments in cannabis, CBD and psychedelics. In 2013 Stephanie gained her BA in English and Media, focusing on journalism and propaganda, and in 2015, received her National Council for the Training of Journalists (NCTJ) diploma whilst working as a reporter in North Wales. Stephanie has a specialism in Medical Cannabis: The Health Effects of THC and CBD through the University of Colorado, Boulder, and a certificate from the Medical Cannabis Clinicians Society on \"Medical Cannabis Explained\".","sameAs":["https:\/\/psychedelichealth.co.uk","https:\/\/twitter.com\/https:\/\/twitter.com\/steph_jprice"],"url":"https:\/\/psychedelichealth.co.uk\/author\/stephanieprice\/"}]}},"amp_enabled":true,"_links":{"self":[{"href":"https:\/\/psychedelichealth.co.uk\/wp-json\/wp\/v2\/posts\/17261"}],"collection":[{"href":"https:\/\/psychedelichealth.co.uk\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/psychedelichealth.co.uk\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/psychedelichealth.co.uk\/wp-json\/wp\/v2\/users\/20"}],"replies":[{"embeddable":true,"href":"https:\/\/psychedelichealth.co.uk\/wp-json\/wp\/v2\/comments?post=17261"}],"version-history":[{"count":0,"href":"https:\/\/psychedelichealth.co.uk\/wp-json\/wp\/v2\/posts\/17261\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/psychedelichealth.co.uk\/wp-json\/wp\/v2\/media\/17262"}],"wp:attachment":[{"href":"https:\/\/psychedelichealth.co.uk\/wp-json\/wp\/v2\/media?parent=17261"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/psychedelichealth.co.uk\/wp-json\/wp\/v2\/categories?post=17261"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/psychedelichealth.co.uk\/wp-json\/wp\/v2\/tags?post=17261"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}